IMI holds eight worldwide patents for our breakthrough research relating to Hypoestoxide, and we have been published in the world's leading scientific journals. 

 

Patents

  1. Compositions and Methods for Immunosuppressing (JO-4) Ojo-Amaize et al. ( U.S. Patent No.: 5,801,193)
  2. Immunosuppression by administration of N6, N6-disubstituted cAMP's, analogues thereof and related nucleosides. Ojo-Amaize et al, (U.S. Patent No.: 5,747,474)
  3. Derivatives of Hypoestoxide and Related Compounds. Cottam et al (U.S. Patent No.: 8,124,654 B2).
  4. Method for Immunosuppressing for Graft-Versus-Host Disease (Continuation-in-part). Ojo-Amaize et al. (U.S. Patent No.: 5,968,912)
  5. Hypoestoxides, Derivatives and Agonists thereof, for use as Antiviral agents Ojo-Amaize et al. (U.S. Patent No.: 6,001,871)
  6. Hypoestoxides, Derivatives and Agonists thereof, for use as Anticancer agents Ojo-Amaize et al. (U.S. Patent No.: 5,994,328)
  7. Pharmaceutical Compositions for Immunosuppression, Anticancer and Antiviral Treatment. Ojo-Amaize et al. ( Patent No.:W0 98/46222)
  8. Hypoestoxide, Derivatives, Related Compounds, and Agonists thereof for Treatment or Prevention of Neurodegenerative Diseases. Cottam et al (Pub. No.: WO/2016/144441) 

PUBlications